Spermatogenesis occurs within the testis of adult males by a complex and ve
ry well organized process. Breakthroughs in techniques such as cryopreserva
tion and culture of spermatogenic cells and the maturation of these cells i
n exogenous testes after transplantation renewed the interest in this proce
ss. Transplantation of spermatogenic cells from a donor to a recipient anim
al needs a preparatory step that consists in the elimination of the endogen
ous population of spermatogenic cells. The most common method used to empty
the seminiferous tubules is the treatment with busulfan (1,4-butanediol di
methanesulfonate). Busulfan partially eliminates stem cells because of its
alkylating nature, but a residual component of stem cells survives the trea
tment and competes in the regeneration of the testis with transplanted cell
s. Estradiol has also been used as an agent that causes a delay in the proc
ess of spermatogenesis by altering its hormonal stimulation, although it do
es not affect the spermatogonia population. Therefore, we have tested diffe
rent treatments with busulfan, estradiol benzoate, and also an agonist of t
he chorionic gonadotrophin-releasing hormone,leuprolide acetate, for the in
hibition of endogenous spermatogenesis. We have found that a combination of
estradiol, busulfan, and leuprolide can destroy the population of endogeno
us spermatogenic cells without altering Sertoli cells and maintains the opt
imal environment needed to allow the development of transplanted cells.